Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-002465
Filing Date
2017-03-16
Accepted
2017-03-16 16:33:59
Documents
1
Period of Report
2017-03-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4031417nicholson_actinium.html 4  
1 OWNERSHIP DOCUMENT f4031417nicholson_actinium.xml 4 3943
  Complete submission text file 0001213900-17-002465.txt   5488
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 103 CHILDS ROAD BASKIN RIDGE NJ 07092
Business Address
Nicholson, C. David (Reporting) CIK: 0001636168 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 17694985